Background: Low-dose methoxyflurane and nitrous oxide (NO; 50:50 with oxygen) are both self-administered, self-titrated, rapid-acting, nonnarcotic, and noninvasive inhalational agents with similar onset times of pain relief. The aim of this review was to compare the clinical efficacy, safety, and tolerability of these analgesics in emergency care.

Materials And Methods: A systematic literature search and review according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were performed using Embase, Medline, the Cochrane Library, several clinical trial registers, and emergency-medicine conference material.

Results: Although both compounds have been used for many years in emergency care, the search found only a few controlled studies and no head-to-head trials performed in this setting. Two double-blind, randomized studies comparing their respective study medication (low-dose methoxyflurane or NO) to placebo were identified that could be compared in an indirect approach by using placebo as a bridging comparator. Both agents provided rapid pain relief to trauma patients, with no significant differences between them; both treatments were generally well tolerated.

Conclusion: Both low-dose methoxyflurane and NO are suitable options for the pain treatment of trauma patients in the emergency setting. Due to the ease of administration and portability, inhaled low-dose methoxyflurane, however, may not only offer advantages in emergency situations in remote or difficult-to-reach locations and mass-casualty situations but also be of significant value in urban and rural environments.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741984PMC
http://dx.doi.org/10.2147/JPR.S150600DOI Listing

Publication Analysis

Top Keywords

low-dose methoxyflurane
20
emergency setting
8
methoxyflurane nitrous
8
pain relief
8
trauma patients
8
emergency
5
low-dose
5
methoxyflurane
5
management trauma
4
pain
4

Similar Publications

Introduction: Methoxyflurane (MEO F) (Penthrox™) is an inhaled, self-administered, non-opioid analgesic approved by Health Canada for the short-term relief of moderate to severe acute pain associated with trauma or interventional medical procedures. In this pilot study, we evaluated the feasibility of using MEOF as an anesthetic agent in 11 patients undergoing outpatient cystoscopic procedures.

Methods: The average duration of the procedure was 24 (range 20-35) minutes and this included 10 minutes of administration time of the drug and five minutes of wait time before the procedure.

View Article and Find Full Text PDF

Unlabelled: Skeletal fluorosis is rare and occurs secondary to chronic high amounts of fluoride consumption, manifesting as diffuse osteosclerosis, skeletal pain, connective tissue calcification, and increased fracture risk. Methoxyflurane is a volatile, fluorinated hydrocarbon-inhaled analgesic, and the maximum recommended dose is 15 mL (99.9 % w/w) per wk.

View Article and Find Full Text PDF

Background: The NHS has the target of reducing its carbon emission by 80% by 2032. Part of its strategy is using pharmaceuticals with a less harmful impact on the environment. Nitrous oxide is currently used widely within the NHS.

View Article and Find Full Text PDF

Background: Low-dose analgesic methoxyflurane (Penthrox) was approved in Europe for emergency relief of moderate to severe pain in conscious adults with trauma in 2015. A comparative post-authorisation safety study (PASS) was conducted to assess the risk of hepatotoxicity and nephrotoxicity with methoxyflurane during routine clinical practice.

Methods: This was a comparative hybrid prospective-retrospective cohort study.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness of self-administered low-dose methoxyflurane on managing trauma pain in patients outside the emergency department during the COVID-19 pandemic at Bichat University Medical Center in Paris.
  • It involved two groups: a control group receiving standard pain management and an intervention group using methoxyflurane alongside standard treatments.
  • Results showed both groups reported lower pain levels over time, with the intervention group experiencing a greater reduction between specific time points, indicating methoxyflurane may enhance pain relief in similar patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!